Isolated hypoxic hepatic perfusion with melphalan in patients with irresectable ocular melanoma metastases. [electronic resource]
- European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology May 2009
- 539-45 p. digital
Publication Type: Journal Article
1532-2157
10.1016/j.ejso.2008.07.004 doi
Aged Antineoplastic Agents, Alkylating--therapeutic use Chemotherapy, Cancer, Regional Perfusion--methods Eye Neoplasms--pathology Female Humans Liver Neoplasms--drug therapy Male Melanoma--drug therapy Melphalan--therapeutic use Middle Aged Treatment Outcome